Skip to content

Multicenter Pilot Study to Describe the Performance of a New Device in Patients With Colostomy

Multicenter Pilot Study to Describe the Performance of a New Device in Patients With Colostomy

Status
Terminated
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02602236
Enrollment
31
Registered
2015-11-11
Start date
2015-11-30
Completion date
2016-10-31
Last updated
2017-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colostomy

Brief summary

The study evaluates the efficacy of a new 2-piece appliance in patients with colostomy.

Interventions

DEVICEAOS-C2000-B

1 base plate for 2 or 3 days and 1 to 4 collection special pouch per day

Sponsors

BBraun Medical SAS
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patient is at least 18 years old * Patient having a colostomy with a diameter less than 30 mm for users of Ø 55 mm pouches or having a colostomy with a diameter less than 40 mm for users of Ø 65 mm pouches * Patient having a colostomy for at least 1 month * Patient using currently the two-piece flat ostomy appliance Flexima®/Softima® 3S for at least 2 weeks and being satisfied * Patient having a stoma protusion smaller than or equal to 1.5 cm * Patient capable to apply and remove the appliance himself or with the help of a caregiver (except health care professional) * Patient having a mental capacity to participate to the study (i.e. to understand the study and to answer to the questions) * Patient agreeing to test the new appliance during the training phase (5±3 days) and during the study device usage phase (14±3 days) * Patient covered by social security

Exclusion criteria

* Patient experiencing repeated leakages with the usual pouching system * Patient currently suffering from peristomal skin complications (bleeding or red and broken skin at the time of inclusion) * Patient receiving or having received, within the last month, chemotherapy, radiotherapy or corticotherapy * Patient already participating in another clinical study or who have previously participated in this investigation * Pregnant or breast-feeding woman

Design outcomes

Primary

MeasureTime frameDescription
Description of efficacy in term of type of bag deployment and leakage preventionAt least 1 time per day during 14±3 daysAfter each change of the investigational product, the patient will describe on a 3-point scale the type of deployment manual, spontaneous - in link with stools or gas, spontaneous - no link with stools or gas

Secondary

MeasureTime frameDescription
Ease of bag deployment14±3 daysEvaluation with a questionnaire (4-points very satisfying to not at all satisfying)
Peristomal skin evaluation with DET score scalebaseline and 5±3 days and 14±3 days
Ease of special bag handling14±3 daysEvaluation with a questionnaire (4-points very satisfying to not at all satisfying)
Investigational product bag ease of use of gas release button14±3 daysEvaluation with a questionnaire (4-points very satisfying to not at all satisfying)
Ease of control of gas release button14±3 daysEvaluation with a questionnaire (4-points very satisfying to not at all satisfying)
General impression about the investigational device before use14±3 daysEvaluation with a questionnaire (4-points very satisfying to not at all satisfying)
Investigational device wearing comfort14±3 daysEvaluation with a questionnaire (4-points very satisfying to not at all satisfying)
Investigational device flexibility14±3 daysEvaluation with a questionnaire (4-points very satisfying to not at all satisfying)
Investigational device discretion14±3 daysEvaluation with a questionnaire (4-points very satisfying to not at all satisfying)
Ease of base plate handling14±3 daysEvaluation with a questionnaire (4-points very satisfying to not at all satisfying)
Investigational device adhesivity during wear time14±3 daysEvaluation with a questionnaire (4-points very satisfying to not at all satisfying)
Investigational device filter performance with deployed bag14±3 daysEvaluation with a questionnaire (4-points very satisfying to not at all satisfying)
Investigational device filter performance with undeployed bag14±3 daysEvaluation with a questionnaire (4-points very satisfying to not at all satisfying)
Investigational product bag deployment reasonAt each bag change during 14±3 daysEvaluation with a questionnaire (4-points very satisfying to not at all satisfying)
Noise during Investigational device wear time14±3 daysEvaluation with a questionnaire (4-points very satisfying to not at all satisfying)
Overall satisfaction questionnaire of the collection volume of the bag of the Investigational device14±3 days
Overall security feeling questionnaire with the Investigational device14±3 days
Overall satisfaction questionnaire with the Investigational device14±3 days
Overall satisfaction questionnaire regarding bag deployment of the Investigational device14±3 days
Overall satisfaction questionnaire with cap cover of the Investigational device14±3 days
General impression about body image during use of the investigational product14±3 days(4-points very satisfying to not at all satisfying)
Assessment questionnaire of willingness to use and the frequency of use in the future14±3 days
Assessment of the investigational device wear time14±3 days
Assessment questionnaire preference between the investigational device and usual appliance14±3 days
Assessment of use of accessoriesAt each bag change during 14±3 daysChoice between some accessories
Assessment of the quality of life with Stoma-QoL questionnaireAt baseline, at 5±3 days and 14±3 days
Number of participants with Adverse Event as a measure of safety and tolerabilityAt baseline, at 5±3 days and 14±3 days
Efficacy of Investigational device gas release button14±3 daysEvaluation with a questionnaire (4-points very satisfying to not at all satisfying)

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026